HomeJSPR • NASDAQ
add
Jasper Therapeutics Inc
Previous close
$22.01
Day range
$20.97 - $23.49
Year range
$4.00 - $31.01
Market cap
326.42M USD
Avg Volume
104.34K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 15.07M | 8.07% |
Net income | -13.73M | 3.73% |
Net profit margin | — | — |
Earnings per share | -1.03 | 29.88% |
EBITDA | -14.78M | -8.13% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 118.48M | -8.44% |
Total assets | 125.96M | -9.22% |
Total liabilities | 12.73M | -6.09% |
Total equity | 113.23M | — |
Shares outstanding | 15.09M | — |
Price to book | 2.93 | — |
Return on assets | -34.12% | — |
Return on capital | -38.25% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -13.73M | 3.73% |
Cash from operations | -15.74M | -52.26% |
Cash from investing | -25.00K | 3.85% |
Cash from financing | 47.35M | -53.36% |
Net change in cash | 31.59M | -65.35% |
Free cash flow | -11.26M | -86.73% |
About
Founded
2019
Headquarters
Website
Employees
45